No clear link between local food and cancer risk in glassworks areas

by Linköping UniversityCredit: CC0 Public DomainThere is no clear link between cancer incidence and locally produced food from an area with a history of glass manufacture with contaminated soil,

Updated on: May 05,2024

No clear link between local food and cancer risk in glassworks areas

by Linköping UniversityCredit: CC0 Public DomainThere is no clear link between cancer incidence and locally produced food from an area with a history of glass manufacture with contaminated soil,

Updated on:May 05,2024

New tool charts differentiation landscape of acute myeloid leukemia

by Center for Genomic RegulationGraphical Abstract. Credit:Cell Stem Cell(2023). DOI: 10.1016/j.stem.2023.04.001Researchers have developed a new method to distinguish between cancerous and

Updated on: January 13,2024

New tool charts differentiation landscape of acute myeloid leukemia

by Center for Genomic RegulationGraphical Abstract. Credit:Cell Stem Cell(2023). DOI: 10.1016/j.stem.2023.04.001Researchers have developed a new method to distinguish between cancerous and

Updated on:January 13,2024

Researchers discover iron-targeting approaches to halt proliferation of cancer cells

by University of Arizona(From left) Yu-Shien Sung, doctoral student in the Tomat Lab, and University of Arizona Cancer Center member Elisa Tomat, PhD, are studying an iron-targeting molecule that

Updated on: February 20,2024

Researchers discover iron-targeting approaches to halt proliferation of cancer cells

by University of Arizona(From left) Yu-Shien Sung, doctoral student in the Tomat Lab, and University of Arizona Cancer Center member Elisa Tomat, PhD, are studying an iron-targeting molecule that

Updated on:February 20,2024

Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence

by NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% w

Updated on: February 20,2024

Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence

by NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% w

Updated on:February 20,2024

Software improves the ability to pinpoint specific genetic mutations that drive cancer

by Colin Poitras,Yale UniversityCredit: Unsplash/CC0 Public DomainA new open-source software package calledcancereffectsizeRdeveloped by the Townsend Lab greatly improves the ability

Updated on: January 03,2024

Software improves the ability to pinpoint specific genetic mutations that drive cancer

by Colin Poitras,Yale UniversityCredit: Unsplash/CC0 Public DomainA new open-source software package calledcancereffectsizeRdeveloped by the Townsend Lab greatly improves the ability

Updated on:January 03,2024

Study unveils the engagement of different cortical networks while humans are unconscious

by Ingrid Fadelli , Medical XpressCredit:Neuron(2023). DOI: 10.1016/j.neuron.2023.08.007States of unconsciousness, such as those that occur during sleep or while under the effect of anesth

Updated on: July 02,2024

Study unveils the engagement of different cortical networks while humans are unconscious

by Ingrid Fadelli , Medical XpressCredit:Neuron(2023). DOI: 10.1016/j.neuron.2023.08.007States of unconsciousness, such as those that occur during sleep or while under the effect of anesth

Updated on:July 02,2024

Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

by Science China PressKnockdown of LTA4H resulted in an attenuated tumor growth and ascites formation. Flow cytometry results showed significantly increased ratio of M1 to M2 macrophages and perc

Updated on: March 20,2024

Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

by Science China PressKnockdown of LTA4H resulted in an attenuated tumor growth and ascites formation. Flow cytometry results showed significantly increased ratio of M1 to M2 macrophages and perc

Updated on:March 20,2024

Patient cost responsibility up for guideline-discordant care

(HealthDay)—For patients with metastatic breast cancer (MBC), receipt of National Comprehensive Cancer Network Guideline-discordant care is associated with higher patient cost responsibility, accordin

Updated on: April 10,2024

Patient cost responsibility up for guideline-discordant care

(HealthDay)—For patients with metastatic breast cancer (MBC), receipt of National Comprehensive Cancer Network Guideline-discordant care is associated with higher patient cost responsibility, accordin

Updated on:April 10,2024

Expert discusses the impact and potential of cancer prevention

by Anne Trafton,Massachusetts Institute of TechnologyGreat progress has been made in reducing the cancer death toll through better prevention and screening, according to a new article by MIT Pro

Updated on: April 01,2024

Expert discusses the impact and potential of cancer prevention

by Anne Trafton,Massachusetts Institute of TechnologyGreat progress has been made in reducing the cancer death toll through better prevention and screening, according to a new article by MIT Pro

Updated on:April 01,2024

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Updated on: March 30,2024

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Updated on:March 30,2024

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC

Updated on: May 17,2024

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC

Updated on:May 17,2024

Private and secure generative AI tool supports operations and research in a cancer center

byDana-Farber Cancer InstituteCredit: CC0 Public DomainDana-Farber Cancer Institute has implemented an artificial intelligence (AI) application intended for general use in a medical center or ho

Updated on: March 30,2024

Private and secure generative AI tool supports operations and research in a cancer center

byDana-Farber Cancer InstituteCredit: CC0 Public DomainDana-Farber Cancer Institute has implemented an artificial intelligence (AI) application intended for general use in a medical center or ho

Updated on:March 30,2024